Occlutech’s atrial flow regulator (AFR) — a cardiac implant — received breakthrough device designation from the U.S. Food and…
Articles by Patrícia Silva, PhD
Roivant recently announced the launch of two new business units, Roivant Pharma and Roivant Health, as well as the creation of…
Denovo Biopharma recently entered an exclusive global license agreement with Stanford University School of Medicine to further develop…
The non-profit Team PHenomenal Hope is helping Puerto Ricans with pulmonary hypertension (PH) during the ongoing power outage…
Credit: phaware Every year, World PH Day is celebrated on May 5. This year the virtual non-profit…
The University of Virginia’s (UVA) Pulmonary Hypertension Center has been recognized as a Center of Comprehensive Care by the…
Cardiome recently shared an update on the development of its therapeutic portfolio, including Trevyent (treprostinil injection) for the treatment…
An Ochsner Health System facility in New Orleans has received Pulmonary Hypertension Association care center accreditation. The association accredits care centers…
The NYU Langone Transplant Institute recently launched a new lung transplant program to offer lung disease patients in…
Liquidia Technologies has started a Phase 3 clinical trial to evaluate LIQ861 as a treatment for pulmonary arterial hypertension. LIQ861…
Bellerophon Therapeutics has enrolled the first patient in a Phase 2b clinical trial evaluating INOpulse as a treatment for pulmonary…
A report about life with pulmonary arterial hypertension (PAH) as a young person, created by young patients worldwide, addresses…